Source: NS Medical Devices

ProciseDx: ProciseDx secures FDA clearance for adalimumab, infliximab drug monitoring tests

The post ProciseDx secures FDA clearance for adalimumab, infliximab drug monitoring tests appeared first on NS Medical Devices.

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Peter Westlake

CEO Approval Rating

90/100

ProciseDx is a California-based medical device company that designs and distributes point-of-care diagnostic devices for the healthcare industry.